Xencor, Inc. Share Price
NASDAQ: XNCR | Mid CapXencor, Inc. Stock Performance
Xencor, Inc. Share Price Today
As of 30 October 2026, Xencor, Inc.'s share price is $29.18. The stock opened at $30.19, compared to its previous close of $30.00. During today's trading session, Xencor, Inc.'s share price traded between $28.99 and $30.51, with an average price of $29.75. Over the past 52 weeks, the stock has recorded a high of $33.28 and a low of $10.38. In terms of performance, Xencor, Inc.'s share price has risen by 144.70% over the last six months and is up 98.50% on a year-on-year basis.
Xencor, Inc. Share Price Chart
Xencor, Inc. Quarterly Profit & Loss
All figures in USD
Xencor, Inc. Annual Profit & Loss
All figures in USD
About Xencor, Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
Xencor, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $24.75 | $29.23 | +16.90% |
Sep 2026 | $27.17 | $25.00 | -13.22% |
Aug 2026 | $20.24 | $28.81 | +42.34% |
Jul 2026 | $15.97 | $20.24 | +25.56% |
Jun 2026 | $11.79 | $16.12 | +35.80% |
May 2026 | $11.84 | $11.87 | -0.46% |
Apr 2026 | $12.31 | $11.93 | -0.87% |
Mar 2026 | $12.45 | $12.03 | -5.94% |
Feb 2026 | $12.22 | $12.79 | +5.88% |
Jan 2026 | $15.24 | $12.08 | -21.05% |
Dec 2025 | $17.00 | $15.30 | -11.56% |
Nov 2025 | $14.49 | $17.30 | +17.69% |